{"id":"W4296529454","doi":"10.1016/s2152-2650(22)00699-1","title":"Oral Abstract: ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Vincristine; Medicine; Doxorubicin; Rituximab; Cyclophosphamide; CHOP; Internal medicine; Oncology; Chemotherapy; Gastroenterology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008543371,0.0008169354,0.001428198,0.0002723236,0.0002563623,0.001149564,0.0007696057,0.001004405,0.01319584],"category_scores_gemma":[0.000649623,0.0003570571,0.001061535,0.0003621108,0.000627855,0.0005580896,0.0003017256,0.002073655,0.001927414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009665521,"about_ca_system_score_gemma":0.0008520895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001427141,"about_ca_topic_score_gemma":0.002770707,"domain_scores_codex":[0.9996985,0.0001495772,0.00001507648,0.00005118264,0.00003005955,0.0000555655],"domain_scores_gemma":[0.9996129,0.0001138187,0.00007520981,0.00001853893,0.00002115586,0.0001584341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9099709,0.00565737,0.001873118,0.0005691188,0.001448436,0.00006810713,0.00004157394,0.001158129,0.007516254,0.0002764325,0.006979473,0.06444115],"study_design_scores_gemma":[0.817368,0.1561344,0.01446211,0.00009935424,0.001575222,0.0001574511,0.00005777705,0.001081165,0.002197082,0.0002739551,0.006564751,0.00002875921],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9653226,0.0126385,0.0006994526,0.002247181,0.0009891388,0.001232174,0.006043997,0.0002753609,0.01055166],"genre_scores_gemma":[0.9778801,0.00475007,0.0007647403,0.001504927,0.000520254,0.0005833502,0.004791039,0.0000642935,0.009141412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01319584,"threshold_uncertainty_score":0.04414451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01905922969332775,"score_gpt":0.2903189716064398,"score_spread":0.271259741913112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}